Search Results 7131-7140 of 34511 for oral
Inpatient hospitalization ≥ 2 nights' duration scheduled ³37 days after randomization; or subjects who have received systemic (ie, oral or injected) ...
All women of childbearing potential will use an appropriate contraceptive method including barrier method, oral contraceptive medication, contraceptive device ...
Able to swallow and retain oral medication. Key Exclusion Criteria: Has received more than 1 allo-HSCT. Has received more than 2 days of systemic ...
Use of oral, injected or implanted hormonal methods of contraception or other forms or hormonal contraception that have complete efficacy (failure < 1%).
Use of short-term (< 2 weeks) oral neomycin for acute encephalopathy is acceptable. Current or recent (within 4 weeks) renal replacement therapy; Superimposed ...
Citrate toxicity in excess of Grade 2 (responds to slowing the rate of the citrate anticoagulant infusion and by administering oral calcium carbonate ...
Ability to swallow and retain oral medications. Acceptable hematologic and organ function at screening. Negative pregnancy test (serum) for women of ...
Highly effective methods of birth control include hormonal birth control (oral, intravaginal, transdermal, implantable, or intrauterine), intrauterine ...
Oral and throat cancer; Oropharyngeal cancer; Radiation injury; Salivary gland cancer; Skin cancer · Thyroid cancer · Procedures performed · Intensity-modulated ...
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.